Side-by-side comparison of AI visibility scores, market position, and capabilities
India's leading digital health platform — doctor discovery, telemedicine, clinic software, and health plans. FY25 revenue ~₹350-400 Cr; 2026 IPO preparation underway; expanding to UAE and US.
Practo is India''s largest digital health platform, providing consumers with doctor discovery, online appointment booking, video consultations, health plans, and diagnostic services. On the B2B side, Practo offers clinic management software used by thousands of healthcare providers across India. Founded in Bengaluru, the company serves a broad population seeking affordable and accessible healthcare, with over 2 lakh (200,000) doctors listed. Practo achieved its first fully profitable quarter in late FY2024 and is on track for sustained profitability, with FY2024–25 revenue estimated at ₹350–400 crore. The company expanded to the UAE in 2025 and launched a U.S. care navigation platform in January 2026, targeting an annualized GMV run-rate of $1B by mid-2026. Practo is preparing for a second-half 2026 IPO in India.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.